Background Major depression is one of the most disabling health conditions internationally. In recent years, new generation antidepressant medicines have become very widely …
KE Tansey, M Guipponi, N Perroud, G Bondolfi… - 2012 - journals.plos.org
Background It has been suggested that outcomes of antidepressant treatment for major depressive disorder could be significantly improved if treatment choice is informed by …
Importance Antidepressants are a first line treatment for depression. However, only a third of individuals remit after the first treatment. Genetic variation likely regulates antidepressant …
E Koch, K Krebs, T Jürgenson, L Milani… - European …, 2023 - Elsevier
Antidepressants exhibit a large variation in efficacy in treated individuals, and increasing evidence suggests that individual genetics contribute to antidepressant treatment response …
Individuals with depression differ substantially in their response to treatment with antidepressants. Specific predictors explain only a small proportion of these differences. To …
SW Lim, HH Won, H Kim, W Myung, S Kim, KK Kim… - PLoS …, 2014 - journals.plos.org
Genetic polymorphism contributes to variation in response to drug treatment of depression. We conducted three independent 6-week treatment studies in outpatients with major …
Antidepressants demonstrate modest response rates in the treatment of major depressive disorder (MDD). Despite previous genome-wide association studies (GWAS) of …
J Ward, N Graham, RJ Strawbridge, A Ferguson… - PloS one, 2018 - journals.plos.org
There are currently no reliable approaches for correctly identifying which patients with major depressive disorder (MDD) will respond well to antidepressant therapy. However, recent …
The “antidepressant efficacy” survey (AES) was deployed to> 50,000 23andMe, Inc. research participants to investigate the genetic basis of treatment-resistant depression …